The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The aim of this study is to investigate effects of sevelamer carbonate on reducing TMAO in stage 3b‐4 CKD (pre‐dialysis) patients. The study will also investigate the safety and tolerability of sevelamer carbonate in study population and the effects of sevelamer carbonate on serum p‐cresyl sulfate, indoxyl sulfate, LDL‐C and uric acid.
Epistemonikos ID: e5df8fab7672a7bb3ff3bfb734857b230735359e
First added on: May 21, 2024